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Abstract. We have examined the role of protein phos-
phatase type 1 (PP-1) in mammalian cell mitosis. Im-
munofluorescence using anti-PP-1 antibodies revealed
that PP-1, which is mainly localized in the cytoplasm
of Gl and S phase cells, accumulates in the nucleus
during G2 phase and intensely colocalizes with in-
dividual chromosomes at mitosis. This increase in nu-
clear PP-1 in G2/M cells was confirmed by immuno-
xE phosphorylation and dephosphorylation of pro-
teins plays a pivotal role in the transduction of hor-
monal signals and the regulation of a number ofpath
ways of cellular metabolism (for reviews see references 2,
10). Recently attention has focused on the role of reversible
phosphorylation in the regulation ofthe mammalian cell di-
vision cycle, leading to the identification of a protein kinase
conserved in organisms from yeast to man (26, 27). This ki-
nase, p34cdc2, apparently plays a central role in the entry of
cells into mitosis (27, 29). Through its phosphorylation of
other cellular enzymes, such as the src tyrosine kinase,
p34cdoz appears to modulate changes in cellular morphology
and cytoskeletal organization accompanying the entry of
cellsinto mitosis (24). While little is known ofthe other pro-
teins that contribute to regulating the coordinate passage of
cells through mitosis, the activation of p34c"-2 kinase in-
volves its dephosphorylation, underlining the importance of
protein phosphatases which, by catalyzing specific dephos-
phorylations, may play an integral role in the regulation of
cell division.
One of the most highly conserved enzymes in eucaryotes
is protein phosphatase type 1 (PP-1) .' Indeed, the products
of the bimG gene of Aspergillus nidulans (12), and the
dis2+ gene and the bwsl+ gene of the fission yeast Schizo-
saccharomyces pombe (4, 31) encode proteins that are 86,
82, and 81% identical in amino acid sequence to rabbit skel-
etal muscle PP-1. Recent genetic studies in these lower euca-
ryotic organisms have shown that mutation in these PP-1-like
genescauses mitotic defects in chromosome disjunction and
the separation of nuclei during anaphase (4, 12, 31). These
1. Abbreviation used in this paper: PP-1, protein phosphatase type 1.
© The Rockefeller University Press, 0021-9525/92/03/1421/10 $2.00
TheJournal ofCell Biology, Volume 116, Number 6, March 1992 1421-1430
blotting on subcellular fractions. Microinjection of
neutralizing anti-PP-1 antibodies before division
blocked cells at metaphase, whereas injection of PP-1
in one pole of an anaphase B cell accelerated cytoki-
nesis and the reflattening of the injected cell . These
results reveal a specific cell cycle-dependent redistri-
bution of PP-1 and its involvement in reversing p34cdc2-
induced effects after mid-mitosis in mammalian cells.
putative functions for PP-1 add to its previously demonstrated
roles in the regulation of glycogen and cellular metabolism,
the modulation ofprotein synthesis, and relaxation ofsmooth
muscle (for reviews see references 2, 10) . While the strict
conservation of PP-1 is indicative of its role in the regulation
of a diverse array of fundamental processes, we still do not
know how one enzyme can orchestrate so many events. Bio-
chemical analysis of the catalytic subunit of PP-1 reveals it
can be purified as heterodimer with either of two proteins,
the heat stable inhibitor 2 (15) or a glycogen-binding (G)
component. PP-1 complexed with inhibitor 2 forms a soluble
holoenzymein which PP-1 activity is regulated through a re-
versible phosphorylation reaction (2, 10). Alternatively, a
glycogen-bound holoenzymeidentifiedas PP-1 complexed to
the G component, which anchors PP-1 glycogen, is also reg-
ulated by phosphorylation (16, 17, 33). Other reports have
demonstrated the specific binding of PP-1 to myofibrils (9)
and muscle membranes (where the enzyme is in a form sim-
ilar to that associated with glycogen; reference 9), and an
association with chromatin (19, 23). Taken together these
biochemicalanalyses show the existence of intracellular PP-1-
binding proteins and provide the first clues that the intracel-
lular distribution of PPl activity may be an important aspect
of its regulation.
We have examined the distribution and potential role of
PPl in the mammalian cell division cycle. Immunolocaliza-
tion studies using affinity-purified antibodies specific for
PP-1 reveal that the phosphatase, mainly cytoplasmic in Gl
cells, progressively accumulates into the nucleus as cells
progress through G2 and into mitosis. Such nuclear-
localized PP-1 is tightly associated with condensed chromo-
somes during all stages of mitosis. Microinjection experi-
1421ments indicate an essential role for this nuclear localization
in targeting PP-1 activity which appears to be required for
the exit from mitosis in mammalian cells.
MaterialsandMethods
Phosphatase Purification and Anti-Type 1 Antibody
The 33-kD catalytic fragment ofPRI was purified from rabbitskeletal mus-
cle by the method of Brautigan et al . (5) with the addition of a final step
of Mono-Q chromatography. This preparation is rendered fully active by
treatment with Mn" and digestion with trypsin (5). The catalytic fragment
was dialyzed immediately before use from a stock solution of 0.35 mg/ml
into an injection solution containing 0.3 mg/ml rabbit anti-mouse antisera
(to act as a marker for injected cells) in an injection buffer containing 100
mM K+ glutamate, 39 mM K+ citrate, L0 MM MgS04, pH 7.25, essen-
tially as described elsewhere (13). Antibodies to the catalytic fragment of
PP-1 were produced as described elsewhere (5),and dialyzed into 0.5 x PBS
formicroinjection. These antibodies selectively inhibit PRI without inhibit-
ing or immunoblotting the type 2A catalytic subunit (6). For control antise-
rum, preimmune sheep antibodies were used and dialyzed as described
above. Synchronized REF-52 cells were immunoblotted with anti-PR-1 es-
sentially by the techniques described elsewhere (6). Assessments of PP-1
activity in REF-52 cells were made as described beforeusing phosphorylase
A as a substrate (5), in the presence and absence of okadaic acid (3).
Microinjection and Cell Culture
Rat embryo fibroblast (REF-52) cells (28) were cultured in DME sup-
plemented with 8% FCS in a humidified atmosphere containing 5% C02
essentially asdescribed elsewhere (24). Cells were subcultured2-3 dbefore
use onto either 25-mm-diam glass coverslips (Schutt Laborteknik, Gottin-
gen, Germany) for microinjection studies, or 12-mm glass coverslips for
immunofluorescence. Synchronous cells were obtained by 36 h of serum
deprivation and refeeding as described elsewhere (24). Mitotic cells were
synchronized by serum deprivation and resynchronized at S phase using a
2-mM hydroxyurea block for 12 h. Hydroxyurea was removedby sequential
washing in fresh DME for 1, 5, 10, and 15 min. Under these conditions,
95% ofthe cells enter S phase within the initial hour. Cells were microin-
jected with ultrafine (x+0.2-um outside diameter) microneedles for ana-
phase cells. Immediately after injection, mitotic cells were loaded into
Dvorak-Stortlercontrolledenvironment chambers (Nicholson Precision In-
struments Inc., Gaithersburg, MD) and observed on a heated stage on a
Zeiss Axiophot photomicroscope.
ImmunofluorescenceAnalysis
For immunofluorescence studies, cells were fixed in 3.7% Formalin for 5
min and extracted with acetone (-20°C), and free protein binding sites
were blocked with a brief incubation in PBS containing 0.1% BSA. Alterna-
tively, cells were fixed in -20°C methanol or preextracted in 0.5 % Triton
before formalin fixation as described before (13). Synchronized cells were
stained fordistributionofthe catalyticsubunitofPP-1 usingaffinity-purified
sheep antibodies specific forthe catalytic fragmentofPP-1 diluted 1:100 (5).
After a 1-h incubation, cells were washed and the distribution ofprimary
antibody was determined by staining cells with fluorescein-conjugated rab-
bit anti-sheep affinity-purified antibodies (13). Cells were stained for DNA
with HOESCHT (1 jig/ml, bisbenzimide; Sigma Chemical Co., (La Verpil-
liere Cedex) France), mounted, and photographed as described elsewhere
(25). Microinjected cells were fixed in Formalin as described above before
staining for the distribution ofthe injected antibodies with fluorescein-con-
jugated goat anti-rabbit antibodies (24). Cells were stained for actin micro-
filaments as described elsewhere (13), before being mounted and pho-
tographed.
Cell Fhactionation and Immunoblotting ofExtracts
from Synchronized Cells
Synchronized REF-52 cells growing on 60-nun dishes were treated with 20
uM cytochalasin B (Sigma Chemical Co.) for 30 min, before being washed
once in 25°C PBS, pelleted at 3,000 g, and resuspended in 100 Al (per 60-
mmdish of cells) ofhypotonic buffer (20 mM Hepes, pH 7.2, 10 mM KAc,
1 mM MgAc, 1 mM DTT, 0.5 mM EDTA) containing 20 uM cytochalasin
B. Cells were allowed to swell for 10 min on ice, before lysis by addition
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of NP-40 at 0.1% final and KAc at 100 mM. After 5 min in ice and vortex,
nucleiandmembraneswerepelleted by centrifugation for 10 minat 8,000 g,
resuspended in 100 WI of lysis buffer, and called nuclear fraction (N); the
supernatant was the soluble cytoplasmic fraction (S).
For immunoblotting ofthese fractions withanti-PP-I, 50 ul ofeach frac-
tion (equivalenttohalfa60-mm dish ofcells) was loaded on a 12.5% acryl-
amide gel for analysis by one-dimensional electrophoresis before transfer
on nitrocellulose for immunoblotting with affinity-purified anti-PP-1 (di-
luted 1:200) and staining with anti-sheepperoxidase-conjugated antibodies
and chloronapthol as described before (6).
Results
Immunolocalization ofPRI in Rat Embryo Flibroblasts
during the Cell Division Cycle
To examine the cytolocalization of PP-1 in mammalian cells,
REF-52 cells (28) were synchronized by serum deprivation
as described previously (8, 25). Under these conditions,
upon serum stimulation, cells have a doubling time of 26-
28 h with four phases corresponding to Gl (0-16 h), S phase
(16-20 h), G2 (20-26 h), and mitosis (25-28 h) (24). Syn-
chronized cells, fixed as described in Materials and Meth-
ods, were stained with a sheep polyclonal antibody affin-
ity purified against a 33-kD catalytic fragment of rabbit
skeletal muscle PP-1 (5). This antibody (anti-PP-1) has been
shown to be specific for PP-1 and unreactive with phospha-
tase type 2A (5) . Anti-PP-1 recognized a single protein of
36 kD in growing REF-52 cells (Fig. 1 A). Cells stained in
GI with this anti-PP-1 revealed a distribution for PP-1 mainly
throughoutthe cytoplasm, with only little evidence of stain-
ing in the nucleus (Fig. 1, B and C). A similar distribution
was also observed in quiescent cells, throughout the G1
period and using different methods of fixation of the cells
(formalin or methanol) (data not shown) . This localization,
mainly cytoplasmic, is consistent with both its previous im-
plication in glycogen metabolism (for review see reference
10) and in S6 dephosphorylation (32), and with our observa-
tion that PP-1 appears to play an essential role as the domi-
nant phosphatase in the regulation of actomyosin contractil-
ity in rat embryo fibroblasts (13) . As cells proceeded through
S phase and into G2, there was a progressive increase of the
phosphatase staining into the nucleus. Cells in S phase (18 h
after refeeding) begin to show a low-level staining within
the nucleus (Fig. 1, D and E) in addition to the bright cyto-
plasmic staining. During G2, the levelofnuclear staining for
PR-1 continued to increase until cells reached prophase,
when the level ofnuclear staining was considerably brighter
than in the cytoplasm. Methanol fixation or brief extraction
of cells with 0.1% Triton X-100 before formalin fixation
provided higher contrast images of PP-1 nuclear staining.
Fig. 1, F and G, shows phase-contrast and PP-1 staining of
late G2 cells fixed in formalin afterprior extraction in Triton
X-100 (note the chromatin is beginning to condense in the
cell on the right in F). Moreover, Fig. 1 G was printed ap-
proximately twice as darkly as the other fluorescence panels
to compensate for the brightness of the staining within the
nucleus of the prophase cell. At the onset ofmitosis, nuclear
PP-1 is specifically associated with the condensing chroma-
tin (Fig. 2, A and B), and individual chromosomes are bril-
liantly stained at prometaphase (Fig. 2, C and D) . Afterdis-
assembly of the nuclear envelope, bright staining for PP-1 is
still clearly discerned on the metaphase chromosomes to-
gether with some staining throughout the cell cytoplasm
1422Figure I. Immunolocalization of PP-1 through the cell cycle of mammalian fibroblasts . Rat embryo fibroblasts growing on glass coverslips
were synchronized through 36 h of serum deprivation as described in Materials and Methods . At different times thereafter, cells were fixed
and processed for immunofluorescence using an affinity-purified sheep anti-PP-1 which recognizes a single protein at 36 kD in extracts
of randomly growing REF-52 cells (A) . Shown are phase-contrast images (B, D, and F) and fluorescence micrographs (C, E, and G) of
cells at different times in the cell cycle . B and C show PP-1 distribution in GI cells ; D and E show its distribution in S phase cells ; and
F and G show its distribution in late G2 with one prophase cell in the center of the image . Bars, 5 um .
(Fig . 2 E) . This bright staining ofthe chromosomes remains
through anaphase (Fig . 2 F) and early telophase (Fig . 2 G)
with the chromatin still being clearly stained against the cel-
lular background . This nuclear staining disappears only at
late telophase, when the chromatin is decondensed and the
nucleus has regained its interphase morphology (-I h after
reformation of the nuclear envelope), leaving cells stained
mainly in the cytoplasm like GI cells (Fig. 1 C) . Such im-
ages ofchromatin staining at mitosis were specific to the use
of anti-PPI antibody since this staining pattern was abol-
ished by preincubation of the anti-PP-1 antibodies with an
excess ofPPl (Fig . 2 H, staining of a prometaphase cell) .
Furthermore, this association of PP-1 staining with the chro-
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mosomes of mitotic cells was abolished by treatment of the
fixed cells with DNase 1 (protease free, 0.5 mgIml for 10
min) before immunostaining . Such treatment resulted in a
diffuse staining for PP-1 throughout the cytoplasm ofmitotic
cells (data not shown) . These results show a cell cycle-de-
pendent change in PP-1 distribution, with a gradual increase
in nuclear PP-1 from the end ofGI-S, culminating at mitosis
with an intense staining associated with the condensed chro-
mosomes .
PRI Immunoblotting ofSubcellular Fractions
To confirm that the marked increase in nuclear PP-1 at the
1423Figure 2 . Immunolocalization of PP-1 in mitotic mammalian cells. Synchronized rat embryo fibroblasts growing on glass caverslips were
fixed in methanol as they reached mitosis (mitotic index -15-20%) and stained with affinity-purified anti-PP-1 antibodies as described
for Fig. 1 . Fluorescence micrographs of individual cells stained at various stages of mitosis : (A and B) in early and late prophase, respec-
tively ; (C and D) in prometaphase ; (E) in metaphase ; (F) in anaphase; and (G) in telophase . (H) Staining of a mitotic with the same
anti-PP-1 serum but after preincubation of the antibody with purified PP-1 . Bar, 7 gym .
end ofG2 and during mitosis observed by immunofluores-
cence truly reflected an increase in PP-1 catalytic subunit
abundance in the nuclei, as opposed to the possible unmask-
ing ofan epitopethrough differential association with regula-
tory subunits, we performed fractionation of synchronized
cells for analysis by Western immunoblotting . Cells were
grown on 60-mm plates and synchronized as described
above . Plates of cells were scraped and incubated in a small
volume of hypotonic buffer before lysis with NP-40 (0.1%)
and preparation of the nuclear fractions as described in
Materials and Methods to obtain pelleted nuclear fractions
and cytoplasmic soluble fractions . Before harvesting, cells
were treated with 20 /AM cytochalasin B to disassemble the
actin microfilament networks and thus release the PP-1
bound to actomyosin into the soluble fraction . Fig . 3 shows
the Western blot from GI and G2/M nuclear and soluble
fractions . In GI cells, immunoblotting reveals a 36-kD pro-
tein in the soluble fraction which is detected similarly in the
cytoplasmic soluble extract from G2/M cells (Fig . 3, lanes
GIS and G2S) . In the nuclear fractions, GI cells show only
a faint staining ofthe 36-kD band (Fig . 3, lane GIN) whereas
a much stronger signal is detected at 36 kD in G2/M cell
nuclei (Fig . 3, lane G2N), even though the sample loading
per lane was the same. (Fractions recovered from half a 60-
mm dish of confluent REF52 cells-i .e ., 4-5 x 106 cells-
were loaded per lane ; the equivalence of the loading was also
Figure 3 . Evidence for a nuclear accumulation of PP-1 in G2 cells .
Tb assay the relative abundance and activity ofPP-1 in nuclear and
cytoskeletal compartments of Gl and G2 cells, synchronized cells
were harvested and subcellular fractions prepared as described in
Materials and Methods . The figure shows immunoblotting analysis
of the different fractions from Gl and late G2 cells, using anti-PP-1
affinity-purified antibodies . S andN refer to the cytoplasmic (solu-
ble) and nuclear (insoluble) fractions, respectively .
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checked through red Ponceau staining of the blot before im-
munoblotting.) These data show that an increased associa-
tion of PP-1 with the insoluble fraction occurs during theG2
period of the cell cycle and thus confirm our immunocyto-
localization observation .
Metaphase Arrest after Phosphatase Inhibition
To investigate the potential role of PP-1 during mitosis, since
it appeared that PP-1 underwent nuclear localization during
G2 and atmitosis, we examinedhow neutralizing PP-1 activ-
ity by microinjection ofanti-PP-1 antibodies would affect the
undergoing of mitosis in rat embryo fibroblasts . To obtain
high proportions of mitotic cells, REF-52 cells were syn-
chronized by serum starvation and used 24 h after refeeding .
Cells selected in the earliest phases ofmitosis were microin-
jected with either control antiserum (Fig. 4, A and B) or 0.5
mg/ml affinity-purified anti-PP-1 antibody diluted into 0.5 x
PBS (Fig . 4, C and D) . Cells were injected with antibodies
as they entered mitosis, and fixed 90 min afterwards . Under
usual circumstances, most cells have entered telophase by
this time . Microinjection of the control antibodies (stained
with fluorescein-conjugated anti-sheep antibodies ; Fig . 4 B)
had no discernible effect on the transition ofthe cells through
to telophase, and a pair of brightly stained reflattening cells
is clearly visible inthe marker antibodies stained image (Fig .
4B) . In the phase image (Fig . 4 A), the nuclei in the injected
control cells are already discernible, implying that the enve-
lope is reforming ; this indicates that injection of the control
antiserum did not disrupt the progression ofthe cells through
mitosis . Indeed, cells injected with control antiserum con-
tinued through at least another cell division cycle without ap-
parent deleterious effects (data not shown) . In contrast, cells
injected at the start of mitosis with inhibitory anti-PP-1 anti-
bodies arrested at metaphase (Fig . 4, C and D) . Both the
phase image (Fig . 4 C) and the chromatin staining with
HOECHST (Fig . 4, inset d) show that the injected cell
(stained for the injected antibodies, Fig . 4 D) was arrested
at metaphase with the chromatin clearly aligned across the
center of the cell . None of the cells injected with anti-PP-1
before mitosis (detected by immunofluorescence staining of
injected antibodies) completed mitosis but instead all ar-
rested at metaphase (ti20 cells injected per experiment, per-
1424Figure 4. Microinjection ofantibodies which neutralize PP-1 into late G2 cells blocks the cells at mitotic metaphase . To examine if inhibiting
PP-1 affects mitotic transition, rat embryo fibroblasts growing on glass coverslips were serum synchronized and then resynchronized at
S phase using hydroxyurea . 8 h after release from the hydroxyurea block, as most cells were about to enter mitosis, early prophase cells
were microinjected with 0.5 mg/ml ofaffinity-purified sheep anti-PP-1. Cells were fixed 45 min after injection and stained for the injected
antibody. Shown are phase-contrast (A and C) and fluorescence micrographs showing the distribution of the injected antibody (B and D)
to identify injected cells . A andB show a cell injected with a control antibody solution alone andCandD show a cell injected with anti-PP-1 .
Bar, 7 Am .
formed four times) . This inhibitory effect of anti-PP-1 anti-
body was abolished by treating with 1 mM DTT or boiling
the antibody solution before injection or by preincubating the
antibody with an excess of PP-1, showing that the effect of
mitotic arrest at metaphase was specific to anti-PP-1 anti-
bodies .
Microinjection ofPRl andAnti-PR1 in
Anaphase Cells
To examine the role of PP-1 in the events subsequent to
metaphase, cells were allowed to proceed through to late
anaphase A-early anaphase B before we injected one of the
two sister cells . Under normal conditions sister halves ofthe
same mitotic cell form mirror images ofone another as they
reflatten during telophase, making it simple to assess any
possible changes induced by microinjection . This technique
allows a direct comparison ofthe consequent behavior ofthe
two halves of the same mitotic cell thus providing an endoge-
nous synchronized control . Anaphase cells were injected
with either neutralizing anti-PP-1 antibodies or control an-
tiserum and fixed 45min after microinjection, by which time
mitosis was normally completed and the cells were in
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telophase and completely flat . With control antiserum (Fig.
5, A-C), microinjection of one half of the anaphase pair did
not interfere with the transition through and completion of
mitosis . Indeed, as shown in Fig. 4 A, both halves of the in-
jected mitotic cell (the half which was injected is stained for
antibody in Fig. 5 B) show a similar morphology and actin
staining (Fig . 5 C) . From this we conclude that this microin-
jection technique provides a feasible way to assess the effects
of anti-PP-1 in anaphase/telophase transition . In marked
contrast, the sister half of an anaphase cell injected with
anti-PP-1 antibodies (Fig . 5, D-F ; marked by antibody stain-
ing in Fig. 5 E) clearly arrested with a rounded phenotype
which differs considerably from the flattened morphology of
the uninjected sister half(Fig. 5 D ; note that the injected cell
has been left for 1.5 h after injection and the uninjected sister
cell is clearly in late telophase) . The cell which was injected
with anti-PPI antibodies still closely resembled an ana-
phase B cell . The cell was compact, tightly rounded with
condensed chromatin, and stayed arrested at the stage for
more than 24 h . When cells were injected with anti-PP-1 an-
tibody in both halves ofthe anaphase cell (which usually oc-
curred ifcells were injected too early in anaphase A) neither
half flattened down, whereas injection of control antiserum
1425Figure 5. Inhibition of PP-1 activity in anaphaseA cells arrests further proceeding and prevents anaphase B and telophase transition . Syn-
chronized rat embryo fibroblasts in late G2 were allowed to progress into mitosis . Selected cells were microinjected into one half as the
cells progressed into anaphase B (when the two sister cells begin to form and move poleward), with either control preimmune serum or
affinity-purified anti-PP-1 . Cells were allowed to continue through anaphase and telophase for 50-90 min before fixation and staining for
the distribution ofthe injected antibody (using fluorescein anti-sheep antisera) and F-actin using rhodamine phalloidin . Shown are phase-
contrast (A and D) and fluorescence micrographs showing the distribution ofthe injected antibody (B and E) and F-actin (C and F) . A-C
show a cell injected with control antibodies and D-F show a cell injected with anti-PP-1 antibodies. Bar, 4 pm .
in this case did not hinder mitosis which proceeded nor-
mally, with both halves becoming fully flattened (data not
shown) . Again, if the antibody was denatured (by boiling or
DTT treatment) these effects on mitosis were not observed
(data not shown) . These data show that inhibiting PP-1 activ-
ity during anaphase prevents completion ofcell division, im-
plying that PP-1 still plays an integral role at this stage in
mitosis .
Theconclusion that PP-1 plays anessential role inthecom-
pletion of anaphase/telophase was reinforced by modifying
the experiment described for Fig . 5 by injecting the active
phosphatase enzyme, PP-1, into the separating halves of
anaphase cells . Again, microinjection solutionscontained an
inert antibody to allow identification of microinjected cells.
As shown in Fig . 6, A-C, after injection ofPP-1 into one half
ofan anaphase cell, the injected half(arrowheads) begins to
show flattening ahead of the associated uninjected half such
that by 15 min, the injected cell is visibly much larger than
the uninjected sister cell . If this is allowed to go to comple-
tion, the microinjected cell (marked by antibody staining in
Fig . 6 E) proceeds to complete mitosis within 15-25 min,
well in advance of the other uninjected half (Fig. 6 D) . In
these cases, the injected sister cell became completely flat
with a reassembled nuclear envelope, differing markedly
from the uninjected sister cell which was still rounded with
condensed chromatin .
These data reinforce our observation with anti-PP-1 anti-
bodies, that PP-1 plays an essential role in the completion of
mammalian cell division . The observation that increasing
the level of PP-1 at anaphase markedly accelerated the
spreading oftelophase cells strongly supports the conclusion
that PP-1 activity plays a key role in the exit from mitosis and
must be tightly regulated during the early stages in the mi-
The Journal of Cell Biology, Volume 116, 1992
totic cell . In this respect the targeting of PP-1 in the nucleus
of prophase cells and onto the condensed chromatin of mi-
totic cells may be implicit in such a regulatory process.
Discussion
We have examined both the intracellular distribution of PP-1
and its participation in the mammalian cell division cycle,
particularly in mitosis . Immunofluorescence staining ofsyn-
chronized rat embryo fibroblasts revealed PP-1 is differen-
tially localized during the cell cycle, and undergoes a marked
relocation into the nucleus at the end of the G2 phase, cul-
minating in intense staining of the condensed chromosomes
during mitosis . This increase in nuclear PP-1 at the G2/M
transition was also observed by immunoblotting on fraction-
ated cells . Experiments using microinjection of anti-PP-1 or
PP-1 show clearly the continuous involvement of PP-1 after
mid-mitosis in the events required for the completion of cell
division from metaphase onward. Specific inhibition of PP-1
activity in mitotic cells, through microinjection of neutral-
izing antibodies directed against PP-1, blocked cells in meta-
phase when injected in late G2/early prophase cells, and
stopped the progression from anaphase to telophase when
injected into an anaphase cell . Conversely, microinjection of
the free PP-1 catalytic fragment into onepole ofan anaphase
cell accelerated the reflattening and completion oftelophase
of the daughter cell from the injected half.
Di fferential Localization ofPP-1 during the
Mammalian Cell Cycle
Using affinity-purified anti-PP-1 antibodies, we have deter-
mined distinct changes in locale of PP-1 as cells proceed
1426Figure6 . Microinjection ofPP-1 during anaphaseAaccelerates the rate ofexit of cells through mitosis . Ratembryo fibroblasts synchronized
through serum starvation and hydroxyurea were allowed to proceed into mitosis before selected cells were microinjected into one pole
of an anaphase B cell. Cells were injected with 0.5 mg/ml of purified catalytic fragment ofPRl and photographed on the microscope
stage. Shown are phase-contrast micrographs of living cells immediately after injection (A, 1 min ; B, 5 min; C, 15 min) ; and cells fixed
20 min after injection inDandE . E shows the injected cell as detected by staining for the presence of the marker antibody. The injected
cell is indicated in each panel (arrowhead) . Bars : (C) 10 gm ; (E) 4 Ftm .
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1427through their division cycle. Our observation that in quies-
cent or GI cells the phosphatase was localized principally in
the cytoplasm is in agreement with its previous implication
in glycogen metabolism (for review see reference 10), its
previous implication in the modulation of S6 phosphoryla-
tion (32), and with our previous study concluding that PP-1
has an active role in the maintenance ofactomyosin dynamics
of interphase fibroblast contractility (13) . Throughout G2,
the staining for PP-1 progressively increased within the nu-
cleus, culminating in the bright staining for PP-1 on condensed
chromosomes. PP-1 has been previously reported to bind to
chromatin and be releasedby 0.5 M NaCl or DNasedigestion
but no relation to the cell cycle was examined (19, 23). Fur-
thermore, this differential location of PP-1 during the cell cy-
cle was confirmed by immunoblotting on subcellular frac-
tions which showed a progressive increase in PP-1 associated
with the nuclear fraction as cells progressed toward G2/M.
One of the intriguing questions raised by our observation
concerns the processes regulating this increase in nuclear lo-
cation of PP-1. Proteins the size of PP-1 (35 kD) have been
shown to freely diffuse into the nucleus where they require
binding to an immobile component to maintain nuclear lo-
calization. Alternatively, proteins above 60 kD require
specific sequences, usually comprised of several contiguous
lysines or arginines for translocation into the nucleus. A dis-
tinguishing feature of the PP-1 catalytic subunit (not present
in the type 2A phosphatase) is a cluster of basic residues lo-
cated at the carboxyl terminus. Although not seemingly re-
quired for nuclear relocation, this feature is conserved in
PP-1 from mammals, Drosophila (11), and fungi (Aspergillus
nidulans, Schizosaccharomyces pombe; references 4, 12,
30). Additionally, the relocation mechanism could involve
the reversible phosphorylation of the PP-1 catalytic subunit
or a specific binding subunit in the nucleus by a cell cy-
cle-dependent kinase activity. However, no evidence yet ex-
ists for the in vivo phosphorylation of the PP-1 36-kD cata-
lytic subunit. In vitro, PP-1 has been reported to be
phosphorylated at a COOH-terminal site by the protein tyro-
sine kinase pp60--, a phosphorylation which decreases
PP1 activity (20). PP-1 could also be released from a cyto-
plasmic site in response to an increased phosphorylation of
some of its regulatory subunits. It has been shown that PP-1
dissociates from the G subunit that anchors it to glycogen
when this G subunit becomes phosphorylated by the cAMP-
dependent protein kinase (A-kinase) in vitro (16, 17), a reac-
tion which may involve other kinases (14) . In this respect,
other protein kinases, the activity of which fluctuates during
the cell division cycle, such as p34cdo', c-mos, c-src, c-abl,
and also the proteins of the cyclin family which accumulate
as the cell proceeds to mitosis, are good potential candidates
to regulate the binding of PP-1 to either cytoplasmic or nu-
clear sites. Additionally, PP-1 may bind to one or more
specific proteins in the nucleus after their cell cycle-depen-
dent phosphorylation, forming a PP-1 binding site on the
chromosomes. Indeed, we have already observed that PP-1
binds with a low Km (-I W) specifically to histone Hl
phosphorylated by cdc2 kinase (but not to unphosphorylated
Hl or phosphorylated by other kinases) (Brautigan, D. L.,
manuscript in preparation). Since histone Hl phosphoryla-
tion is known to gradually augment throughoutthe cell cycle
particularly during G2, a mechanism involving PP-1 binding
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to Hl may account for the gradual increase of PP-1 in the nu-
clear fraction.
Fbtential Function ofPFL1 after Mid-Mitosis in
Metaphase and Anaphase
The question arises, What function does nuclear relocation
of PP-1 at mitosis perform? Mitosis involves profound
changes in cell morphology ; in particular, chromatin con-
densation, disassembly of the cytoskeletal networks, and
breakdown ofthe nuclear envelope. Most ofthese changes-
which occur in cells as they enter mitosis and appear to in-
volve a marked increase in phosphorylation of proteins (in-
cluding the microtubule-associated proteins, vimentin, his-
tones, the nuclear lamins, src, and the cyclins) -have to be
reversed after mid-mitosis after the metaphase-anaphase
transition.
The results of the microinjection studies we have done
with PP-1 and neutralizing antibodies to PP-1 reveal an es-
sential role for this enzyme in the completionofmitosis from
the metaphase stage and still during the transition from
anaphase to telophase. Our observation that anti-PP-1 in-
jected before mitosis blocked cells at metaphase suggests
that PP-1 has its earliest function in the transition of cells
through metaphase into anaphase. This is in agreement with
previous genetic data from both Aspergillus nidulans (12)
and yeast (4, 22, 30) which revealed that PP-1 affected spindle
organization and nuclear separation. More recently, a study
on PP-1 mutant from Drosophila described similar perturba-
tions with cells bearing metaphase-like overcondensed chro-
mosomes (1). Based on the block at metaphase with a
spindle-like structure we observed, one might speculate that
the molecular motors responsible for chromatid separation
are under regulation by phosphorylation and their dephos-
phorylation by PP-1 might be integral to this process. In-
deed, this hypothesis recently found strong support with the
study by Hyman and Mitchison (18) showing that the polarity
of the movement ofmicrotubules on the kinetochores of iso-
lated chromosomes can be reversed in a phosphorylation-
dependent manner. Under conditions in which dephosphory-
lation is inhibited, microtubules are induced to move by the
plus-end (toward the metaphase plate), rather than minus-
end movement (toward the spindle poles), occurring when
dephosphorylation is allowed or phosphorylation is in-
hibited. This implies that the molecular motors in the
kinetochores, responsible for the direction of chromosome
movement, are under control by phosphorylation/dephos-
phorylation. In this respect, there are homologies between
at least two of the potential microtubule motor proteins,
dynein and kinesin, and the actomyosin phosphoprotein my-
osin, which we demonstrated to be a preferential substrate
for PP-1 in vivo (13), and has recently been shown to be also
involved in cytokinesis inDrosophila (21) . It will be interest-
ing to examine if either of the microtubule motor proteins
or other microtubule-associated proteins are also substrates
of PP-1.
Downstream of the metaphase block induced with anti-
PP-1 injection, we observed that the flatteningofmitotic cells
through anaphase B and telophase, leading to the morphol-
ogy of interphase cells, is accelerated by microinjection of
PP-1 and blocked by neutralizing anti-PP-1 antibodies. This
1428strongly supports the view that PP-1 is a key effector in the
process of mitotic exit in mammalian cells. While the spe-
cific functions of PP-1 in mitotic exit remain unknown, we
might speculate that PP-1 is probably involved in the dephos-
phorylation of a variety ofmitosis-specific phosphoproteins,
particularly those substrates for p34cdc2 or the kinases acti-
vated downstream of it.
For example, the reflattening of mitotic cells probably in-
volves the dephosphorylation of intermediate filament pro-
teins which become highly phosphorylated at mitosis and we
have observed that vimentin can be dephosphorylated in vivo
by PP-1 (7) . The nuclear lamins A and C also appear to be
dephosphorylated by PPl in vivo (7); and whilethey are de-
phosphorylated during envelope reassembly, the phospha-
tase responsible remains to be identified. Our observations
strongly suggest that PP-1 may play a role in this process
since half an anaphase A cell injected with anti-PP-1 was
blocked in anaphase and failed to reform an envelope which
had clearly reformed in the uninjected sister cell.
However, all these potential substrates are dephosphory-
lated only after the metaphase-anaphase transition. The fact
that we observed an intense staining for PP-1 on the chroma-
tin as soon as cells enter prophase, while microinjected anti-
bodies to PP-I only blocked cells at metaphase, suggests that
PP-1 activity must be tightly regulated up to this stage. In
light of our recent finding showing an increase of inhibitor
2-one of the two specific heat-stable inhibitors for PP-1, at
S phase and at mitosis (8) -it is tempting to speculate an in-
volvement of inhibitor 2 in the downregulation of the
chromatin-bound PP-1 up to metaphase. However, although
we observed that inhibitor 2 was localized in both the nu-
cleus and cytoplasm in prophase cells, it was never as-
sociated with the chromatin. Alternatively, downregulation
of PP-1 might involve either a direct phosphorylation by
p34cd°2, or PP-1 binding to cyclin subunits (which get rap-
idly degraded at metaphase). However, further studies ofthe
potential interactions of PP-1 with cdc2 subunits will be re-
quired to document any of these possibilities.
Our immunofluorescence and biochemical studies of the
intracellular distribution of PPl shows that it undergoes a
concerted reorganization during the mammalian cell cycle,
while microinjection studies provided direct evidence that
PP-1 regulates a number of events especially in the progres-
sion through mitosis, after the metaphase stage. Together,
these results support the idea that the changes in PP-1 distri-
bution at mitosis play an important role in modulating the
activity ofthis enzyme and suggest that PP-1 might be a ma-
jor phosphatase responsible for dephosphorylating p34cd°z
kinase sites, an hypothesis that now awaits more detailed ex-
amination.
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